Each of Zimmer Biomet's (ZBH) geographic segments and product divisions record year-over-year sales growth at CER.
CONMED's (CNMD) adjusted fourth-quarter sales and earnings reflect disruption due to implementation of a new warehouse management system.
Cardinal Health's (CAH) fiscal second-quarter results benefit from the solid performance of the Pharmaceutical segment.